Overview

Systematic Radioiodine Administration (3.7 GBq I131 After rhTSH) Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up

Status:
Recruiting

Trial end date:
2028-02-01

Target enrollment:

Participant gender:

Summary

This trial is comparing two strategies in intermediate-risk differentiated thyroid cancer patients: Systematic radioiodine administration (3.7 GBq I131 after rhTSH) versus decision of radioiodine treatment guided by a post-operative work-up based on serum Tg values and diagnostic RAI scintigraphy

Phase:

Phase 3

Details

Lead Sponsor:

Centre Francois Baclesse

Collaborator:

French cancer Institute INCa